Adherence to Venous Thromboembolism Prophylaxis in High-Risk Gynecologic Cancer Patients during the Enhanced Recovery after Surgery Era
Article Sidebar
Main Article Content
Abstract
Objectives: Venous thromboembolism (VTE) is a common complication in patients with gynecologic cancer, reducing survival and increasing the financial burden. This study aimed to assess the adherence to VTE prophylaxis and factors that influence physician decisions.
Materials and Methods: This descriptive cross-sectional study was conducted in the Department of Obstetrics and Gynecology, Siriraj Hospital, Thailand. We included patients with gynecologic malignancies undergoing abdominopelvic surgery who were at high risk for VTE (Caprini score ≥ 5). Patient demographics, clinical profiles, and the adherence of the physician to the thromboprophylaxis protocols were evaluated.
Results: From October 2023 to October 2024, 231 patients met the inclusion criteria. The median age was 59 years (interquartile range (IQR) 50–66) and the median body mass index was 24.4 kg/m² (IQR 21.1–28). Most patients (83.2%) had Caprini scores of 5 or 6. 219 (96.5%) patients received mechanical and/or pharmacological prophylaxis. However, only 50 patients (22%) received prophylaxis in accordance with the guidelines. The surgical route was the only factor significantly associated with guideline adherence.
Conclusion: The adherence rate to VTE prophylaxis in perioperative gynecologic malignancy patients was low (22%). Further research is needed to understand barriers to adherence and the clinical consequences of noncompliance.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Barber EL, Clarke-Pearson DL. Prevention of venous thromboembolism in gynecologic oncology surgery. Gynecol Oncol 2017;144:420–7.
Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 2006;243:89–95.
Cohen A, Lim CS, Davies AH. Venous thromboembolism in gynecological malignancy. Int J Gynecol Cancer 2017;27:1970–8.
Jacobson G, Lammli J, Zamba G, Hua L, Goodheart MJ. Thromboembolic events in patients with cervical carcinoma: Incidence and effect on survival. Gynecol Oncol 2009;113:240–4.
Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975–80.
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Gynecology. Prevention of venous thromboembolism in gynecologic surgery: ACOG Practice Bulletin, Number 232. Obstet Gynecol 2021;138:e1–e15.
Falanga A, Ay C, Di Nisio M, Gerotziafas G, Jara-Palomares L, Langer F, et al. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline. Ann Oncol 2023;34:452–67.
Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic therapy and prevention of thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e227S–e77S.
Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, et al. Venous thromboembolism prophylaxis and treatment in patients with cance: ASCO guideline update. J Clin Oncol 2023;41:3063–71.
Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: A review. JAMA Surg 2017;152:292–8.
Geahchan N, Basile M, Tohmeh M, registry D. Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry. Springerplus 2016;5:1541.
Sermsathanasawadi N, Chaivanit T, Suparatchatpun P, Chinsakchai K, Wongwanit C, Ruangsetakit C, et al. A new pretest probability score for diagnosis of lower limb deep vein thrombosis in unselected population of outpatients and inpatients. Phlebology 2017;32:107–14.
Tientong K, Chotikawanich T, Theptong P. Enhanced recovery after surgery versus standard care for elective cesarean deliveries in the tertiary care center, Rajavithi Hospital, Thailand. Thai J Obstet Gynaecol 2023;31: 174–81.
Klangprapan N, Narkwichean A, Luanpholcharoenchai J, Laosooksathit W. Effectiveness of the enhanced recovery after surgery (ERAS) protocol following elective desarean section: A single-center randomized controlled trial. Thai J Obstet Gynaecol 2022;30: 393-402.
Peedicayil A, Weaver A, Li X, Carey E, Cliby W, Mariani A. Incidence and timing of venous thromboembolism after surgery for gynecological cancer. Gynecol Oncol 2011;121:64–9.
Schmeler KM, Wilson GL, Cain K, Munsell MF, Ramirez PT, Soliman PT, et al. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol 2013;128:204–8.
Iannuzzi JC, Rickles AS, Kelly KN, Fleming FJ, Dolan JG, Monson JR, et al. Defining high risk: cost-effectiveness of extended-duration thromboprophylaxis following major oncologic abdominal surgery. J Gastrointest Surg 2014;18:60–8.
Herb JN, Iwai Y, Dunham LN, Stitzenberg KB. Persistent underuse of extended venous thromboembolism prophylaxis in patients undergoing major abdominal cancer operations. J Surg Oncol 2024;129:436–43.
Arunothai S, Sutherasan Y, Panpikoon T, Theerawit P, Angchaisuksiri P, Boonyawat K. Low incidence of deep vein thrombosis in critically ill medical patients in Thais: a prospective study. Res Pract Thromb Haemost 2024;8:102522.
Limpawittayakul P, Rojnuckarin P. Incidence, risk factors of symptomatic venous thromboembolism and risk prediction score in hospitalized cancer patients at Ubon Ratchathani Cancer Hospital. J Hematol Transfus Med 2025;35.109-18.
Wasowicz-Kemps DK, Biesma DH, Schagen van Leeuwen J, Van Ramshorst B. Prophylaxis of venous thromboembolism in general and gynecologic day surgery in The Netherlands. J Thromb Haemost 2006;4:269–71.
Rasmussen MS. Is there a need for antithrombotic prophylaxis during laparascopic surgery? Always. J Thromb Haemost 2005;3:210–1.
Vedovati MC, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, et al. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg 2014;259:665–9.
Sompohnmanas A, Ruengkhachorn I, Jareemit N, Khemworapong K, Achariyapota V. Impact of obesity on treatment and survival outcome in epithelial ovarian cancer patients: A 10-year retrospective study. Thai J Obstet Gynaecol 2025;33:503-14.
Kanthiya K, Janwanitchsthaporn S. Enhanced recovery after surgery protocol and the factors associated with prolonged hospitalization in major gynecologic surgery at Suratthani Cancer Hospital. Thai J Obstet Gynaecol 2023;30:403–12.
Marchocki Z, Norris L, O’Toole S, Gleeson N, Saadeh FA. Patients’ experience and compliance with extended low molecular weight heparin prophylaxis post-surgery for gynecological cancer: a prospective observational study. Int J Gynecol Cancer 2019;29:802–9.
Longo de Oliveira ALM, de Oliveira Pereira RF, Agati LB, Ribeiro CM, Kawamura Suguiura GY, Cioni CH, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after major gynecological cancer surgery: The VALERIA Trial : Venous thromboembolism prophylAxis after gynecoLogical pElvic cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial). Clin Appl Thromb Hemost 2022;28:10760296221132556.
Black KA, Thomas A, Sauro KM, Nelson G. Effect of enhanced recovery after surgery compliance on postoperative venous thromboembolism. BJS Open 2025;9:1-7.
Gonzalez R, Kurtovic K, Habib AS, Ryan ES, Foote J, Pandya D, et al. A quality improvement initiative to reduce venous thromboembolism on a gynecologic oncology service. Gynecol Oncol 2021;162:120–7.
Cassidy MR, Macht RD, Rosenkranz P, Caprini JA, McAneny D. Patterns of failure of a standardized perioperative venous thromboembolism prophylaxis protocol. J Am Coll Surg 2016;222:1074–80.
